(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYELOMA INVESTMENT FUND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYELOMA INVESTMENT FUND

ST13

US500000088935517

Class

36

Filing

88935517

Registration

6171763

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

02/25/2026

Trademark type

Word

Nice classes

36

Filing date

05/27/2020

Registration date

10/06/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/24/2026

Last transaction

02/25/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

04/16/2019

First use in commerce

04/16/2019

Drawing code

4

Owner type

99

Owner location

Norwalk, CT, US

Examiner

LAMONT, MIAH ROSENBERG

Current location

Historical data usage

Holders and representatives

Holders

The Multiple Myeloma Research Foundation, Inc.

Representatives

Jacqueline P. Scheib ROBINSON & COLE LLP

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Investment of funds; Management of a capital investment fund

Publications

History of USPTO decisions and trademark events.

19 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

02/24/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/24/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/23/2026

ES8R

TEAS SECTION 8 RECEIVED

10/06/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/06/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/14/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/14/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/14/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/06/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/31/2020

ALIE

ASSIGNED TO LIE

08/21/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/13/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/13/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/13/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/13/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/13/2020

DOCK

ASSIGNED TO EXAMINER

08/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/16/2020

NWAP

NEW APPLICATION ENTERED

05/30/2020

Continuous trademark protection

Get notified about every new filing that threatens MYELOMA INVESTMENT FUND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.